CHIMERIC THERAPEUTICS LIMITED

0.00%

0.5¢

Market Cap $7.975M

Healthcare Biotechnology

Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company.... Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company. The Company is focused on the discovery, development, and commercialization of cell therapies for patients with cancer. Its pipeline includes CHM 1101 and CHM 2101. Its CHM 1101 (CLTX CAR-T) is a CAR-T therapy developed for the treatment of patients with solid tumors. CHM-1101 is being studied in a Phase 1B clinical trial in recurrent/ progressive glioblastoma. CHM 2101 is a third generation CDH17 CAR T, which is in preclinical development with a planned Phase I clinical trial in neuroendocrine tumors, colorectal, pancreatic and gastric cancer. Its pipeline also includes the CORE-NK platform, a clinically validated, off-the-shelf natural killer (NK) cell therapy platform to their portfolio (CHM 0201). The Company is also focused on the development of NK and CAR NK assets with plans for Phase 1B clinical trials in solid tumors and blood cancers.More

Latest Threads

Tag

Subject

CHM

Comparative Analysis

00:04

28K

00:04

Last post amb005

28K

CHM

Ann: Proposed issue of securities - CHM

14/03/25

8.0K

14/03/25

Last post KrushingIt

8.0K

CHM

Ann: Presentation at NWR Virtual Healthcare Conference

13/03/25

421

13/03/25

Last post

ASX News

421

CHM

Ann: Chimeric announces intention to undertake Entitlement Offer

07/03/25

10K

07/03/25

Last post pfeifer1982

10K

CHM

Charting Only

6 7 8

06/03/25

479

177K

06/03/25

Last post dalts66

479

177K

CHM

Ann: Suspension from Quotation

04/03/25

17K

04/03/25

Last post dalts66

17K

CHM

Ann: Reinstatement to Quotation

04/03/25

359

04/03/25

Last post

ASX News

359

CHM

Ann: Half Year Report and Appendix 4D 31 December 2024

03/03/25

717

03/03/25

Last post Kiwigats

717

See All Discussions

Timeline

Presentation at NWR Virtual Healthcare Conference
13 Mar 08:22	Share

Reinstatement to Quotation
04 Mar 12:09	Share

Proposed issue of securities - CHM
04 Mar 11:59	Share

Chimeric announces intention to undertake Entitlement Offer
04 Mar 11:59	Share

Suspension from Quotation
03 Mar 10:03	Share

Half Year Report and Appendix 4D 31 December 2024
28 Feb 17:34	Share

$4.0m Non-Dilutionary Funding
27 Feb 16:06	Share

Trading Halt
27 Feb 10:05	Share

Pause in Trading
27 Feb 09:46	Share

Application for quotation of securities - CHM
12 Feb 16:50	Share

Prospectus
12 Feb 09:09	Share

Proposed issue of securities - CHM
11 Feb 16:12	Share

UChicago Medicine joins CHM CDH17 trial
10 Feb 09:01	Share

Quarterly Activities/Appendix 4C Cash Flow Report
31 Jan 11:00	Share

Notification regarding unquoted securities - CHM
23 Dec 09:58	Share

Notification of cessation of securities - CHM
23 Dec 09:56	Share

Notification regarding unquoted securities - CHM
23 Dec 09:55	Share

Phase 1B CHM CORE-NK trial advances to newly diagnosed AML
16 Dec 09:48	Share

Change of Director's Interest Notice PH
13 Dec 15:01	Share

Notification regarding unquoted securities - CHM
13 Dec 13:54	Share

Change in substantial holding - PH
11 Dec 17:45	Share

Update - Notification regarding unquoted securities - CHM
10 Dec 20:25	Share

Notice under section 708A
10 Dec 17:55	Share

Application for quotation of securities - CHM
10 Dec 17:51	Share

Notification regarding unquoted securities - CHM
10 Dec 17:45	Share

Notice under section 708A
09 Dec 17:38	Share

Application for quotation of securities - CHM
09 Dec 17:31	Share

Results of Meeting
04 Dec 12:24	Share

Presentation to Extraordinary General Meeting
04 Dec 10:40	Share

Chimeric receives $4.17m R&D tax incentive
28 Nov 09:38	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.5¢		Change 0.000(0.00%)		Mkt cap ! $7.975M

Open	High	Low	Value	Volume
0.5¢	0.5¢	0.5¢	$18.27K	3.655M

Buyers (Bids)

No.	Vol.	Price($)
7	3828708	0.5¢

Sellers (Offers)

Price($)	Vol.	No.
0.6¢	6477643	8

View Market Depth

No.	Vol.	Price($)
2	1050000	0.005
16	6998254	0.004
11	6330997	0.003
4	7400000	0.002
5	22899000	0.001

Price($)	Vol.	No.
0.006	6352643	7
0.007	4845742	11
0.008	2633967	5
0.009	174209	1
0.010	300000	1

Last trade - 13.39pm 14/03/2025 (20 minute delay)

CHM (ASX) Chart

CHIMERIC THERAPEUTICS LIMITED

Latest Threads

Timeline

Featured News

Latest Articles

Chimeric clocks $4.17M R&D tax rebate from Canberra

Chimeric Therapeutics (ASX:CHM) has confirmed its receipt of a $4.17M tax rebate from Canberra for R&D activities.

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Chimeric Therapeutics (ASX:CHM) has reported one leukaemia patient has shown a complete response in its latest drug trial.

Chimeric Therapeutics treats first patient in Advent-AML phase 1B clinical trial

Chimeric Therapeutics (ASX:CHM) has treated the first patient in its Advent-AML phase 1B clinical trial at The University of Texas MD Anderson Cancer Center.

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News